HemaSphere (May 2023)

P07 BORTEZOMIB-MELPHALAN-PREDNISONE (VMP) VS. LENALIDOMIDE-DEXAMETHASONE (RD) IN REAL-LIFE MULTIPLE MYELOMA PATIENTS INELIGIBLE FOR TRANSPLANT: UPDATED ANALYSIS OF THE RANDOMIZED PHASE IV REAL MM TRIAL

  • A. Larocca,
  • M. D’Agostino,
  • N. Giuliani,
  • E. Antonioli,
  • R. Zambello,
  • S. Ronconi,
  • I. D. Vincelli,
  • F. Ciceri,
  • A. P. Falcone,
  • M. Michieli,
  • F. Cattel,
  • A. Capra,
  • M. Grasso,
  • A. M. Cafro,
  • F. Bonello,
  • R. Floris,
  • M. Offidani,
  • E. Sciorsi,
  • G. Pietrantuono,
  • P. Curci,
  • F. Patriarca,
  • M. Cavo,
  • S. Mangiacavalli,
  • G. Benevolo,
  • A. Evangelista,
  • G. Ciccone,
  • M. Boccadoro,
  • B. Bruno,
  • S. Bringhen

DOI
https://doi.org/10.1097/01.HS9.0000936156.32733.12
Journal volume & issue
Vol. 7, no. S2
pp. 12 – 13

Abstract

Read online

No abstracts available.